{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:52:28Z","timestamp":1768009948655,"version":"3.49.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJOP1721"],"award-info":[{"award-number":["JPMJOP1721"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004206","name":"Osaka University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004206","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1053\/j.semnuclmed.2022.02.005","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T10:36:02Z","timestamp":1648204562000},"page":"619-627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Clinical Value of Breast Specific Gamma Imaging and Positron Imaging: An Update"],"prefix":"10.1053","volume":"52","author":[{"given":"Jun","family":"Hatazawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0001","unstructured":"International Agency for Research on Cancer (IARC). Available at: http:\/\/www.iarc.fr. Accessed January 17, 2022"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0002","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1016\/S1470-2045(20)30751-8","article-title":"Medical imaging and nuclear medicine: a Lancet Oncology Commission","volume":"22","author":"Hricak","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0003","unstructured":"Cancer registry of the National Cancer Center Japan. Available at: http:\/\/ganjoho.jp. Accessed January 17, 2022"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0004","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/j.semnuclmed.2013.03.003","article-title":"Radionuclide methods and instrumentation for breast cancer detection and diagnosis","volume":"43","author":"Surti","year":"2013","journal-title":"Seminars Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0005","first-page":"1646","article-title":"Piwnica-Worms D: effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) Technetium (I) in cultured mouse fibroblasts","volume":"31","author":"Chiu","year":"1990","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0006","first-page":"1350","article-title":"A new Tc-99m-labeled myocardial imaging agent, hexakis (t-butylisonitrile) technetium (I) [Tc-99m TBI]: initial experience in the human","volume":"25","author":"Holman","year":"1984","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0007","first-page":"2148","article-title":"Uptake of the cation hexakis (2-methoxy isobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro","volume":"50","author":"Delmon-Moingeon","year":"1990","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0008","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00003072-199203000-00003","article-title":"Clinical experience with 99mTc-MIBI imaging in patients with malignant tumors: preliminary results and comparison with Tl-201","volume":"17","author":"Aktolun","year":"1992","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0009","first-page":"977","article-title":"Functional imaging of multidrug-resistant P-glycoprotein with an organo-technetium complex","volume":"53","author":"Piwnica-Worms","year":"1993","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0010","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1158\/1535-7163.MCT-14-0151","article-title":"Longitudinal time-dependent effects of irradiation on multidrug resistance in a non-s0mall lung cancer cell line","volume":"13","author":"Kohno","year":"2014","journal-title":"Mol Cancer Therapeutics"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0011","first-page":"e659","article-title":"Breast osteoblast-like cells: a reliable early marker for bone metastases from breast cancer","volume":"18","author":"Scimeca","year":"2018","journal-title":"Breast Cancer"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0012","article-title":"99mTc-sestamibi breast imaging: current status, new ideas, and future perspectives","author":"Urbano","year":"2020","journal-title":"Seminars Cancer Biol"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0013","first-page":"1972","article-title":"Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography","volume":"33","author":"Kubota","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0014","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1148\/radiology.179.3.2027989","article-title":"Primary and metastatic breast carcinoma: initial clinical evaluation with the radio-labeled glucose analogue 2-[18F]-fluoro-2-deoxy-D-glucose","volume":"179","author":"Wahl","year":"1991","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0015","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1148\/radiology.187.3.8497624","article-title":"Evaluation of breast masses and axillary lymph nodes with [18F]2-deoxy-2-fluoro-D-glucose PET","volume":"187","author":"Adler","year":"1993","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0016","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12149-021-01582-y","article-title":"Clinical practice guidelines for high-resolution breast PET, 2019 edition","volume":"35","author":"Satoh","year":"2021","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0017","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1007\/s00259-018-4099-8","article-title":"89Zr-tratsuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up","volume":"45","author":"Bensch","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0018","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2010.33.5232","article-title":"Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer","volume":"30","author":"Amir","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0019","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2967\/jnumed.107.047506","article-title":"Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol","volume":"49","author":"Peterson","year":"2008","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2022.02.005_bib0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/MO:18:4:243","article-title":"Treatment resistance of solid tumors: role of hypoxia and anemia","volume":"18","author":"Vaupel","year":"2001","journal-title":"Med Oncol"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0021","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13550-017-0263-6","article-title":"Quantitative evaluation of oxygen metabolism in the intratumoral hypoxia: 18F-fluoromisonidazole and 15O-labelled gases inhalation PET","volume":"7","author":"Watabe","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0022","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"68Ga-FAPI PET\/CT: Biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers","volume":"60","author":"Giesel","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0023","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0024","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1148\/radiology.220.1.r01jl1654","article-title":"Detection of malignant tumors: whole-body PET with fluorine 18 alpha-methyl tyrosine versus FDG-preliminary study","volume":"220","author":"Inoue","year":"2001","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00259-016-3487-1","article-title":"18F-FBPA as a tumor-specific probe of L-type amino acid transporter 1 (LAT1): a comparison study with 18F-FDG and 11C-Methionine PET","volume":"44","author":"Watabe","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0026","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s12149-016-1121-8","article-title":"Assessment of 10B concentration in boron neutron capture therapy: potential of image-guided therapy using 18FBPA PET","volume":"30","author":"Shimosegawa","year":"2016","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0027","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s12149-018-1296-2","article-title":"Preliminary feasibility study on differential diagnosis between radiation-induced cerebral necrosis and recurrent brain tumor by means of [18F]fluoro-borono-phenylalanine PET\/CT","volume":"32","author":"Beshr","year":"2018","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0028","doi-asserted-by":"crossref","unstructured":"Liu Y, Watabe T, Kaneda\u2011Nakashima K, et al: Fibroblast activation protein targeted therapy using [177Lu] FAPI\u201146 compared with [225Ac] FAPI\u201146 in a pancreatic cancer model. Eur J Nucl Med Mol Imaging. doi: 10.1007\/s00259-021-05554-2","DOI":"10.1007\/s00259-021-05554-2"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0029","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/cas.14761","article-title":"\u03b1-Emitting cancer therapy using 211At-AAMT targeting LAT1","volume":"112","author":"Kaneda-Nakashima","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0030","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.18632\/oncotarget.27552","article-title":"Targeted alpha therapy using astatine (211At)-labeled phenylalanine: a preclinical study in glioma bearing mice","volume":"11","author":"Watabe","year":"2020","journal-title":"Oncotarget"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0031","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00259-017-3919-6","article-title":"Antitumor effects of radionuclide treatment using \u03b1-emitting meta-211At-astato-benzylguanidine in a PC12 pheochromocytoma model","volume":"45","author":"Ohshima","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0032","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.semnuclmed.2004.11.002","article-title":"Clinical Impact of 99mTc-sestamibi scintimammography","volume":"35","author":"Taillefer","year":"2005","journal-title":"Seminars Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0033","first-page":"46","article-title":"99mTc-MIBI scintimammography using a dedicated nuclear mammograph","volume":"40","author":"Maini","year":"1999","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2022.02.005_bib0034","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.07.3693","article-title":"Molecular breast imaging: use of a dual-head dedicated gamma camera to detect small breast tumors","volume":"191","author":"Hruska","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0035","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40336-016-0201-z","article-title":"Methodological aspects of 99mTc-sestamibi guided biopsy in breast cancer","volume":"4","author":"Collarino","year":"2016","journal-title":"Clin Trans Imaging"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0036","first-page":"1851","article-title":"Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG","volume":"41","author":"Murthy","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0037","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.2967\/jnumed.109.064345","article-title":"Clinical imaging characteristics of the positron emission mammography camera: PEM Flex Solo II","volume":"50","author":"MacDonald","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0038","first-page":"960","article-title":"Positron emission tomography-guided breast biopsy","volume":"42","author":"Raylman","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0039","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1620\/tjem.245.13","article-title":"Newly developed positron emission tomography (PEM) device for the detection of small breast cancer","volume":"245","author":"Yanai","year":"2018","journal-title":"Tohoku J Exp Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0040","first-page":"13","article-title":"Diagnostic accuracy of positron emission mammography with 18F-fluorodeoxyglucose in breast cancer tumor of less than 20 mm","volume":"7","author":"Yano","year":"2019","journal-title":"Asian Ocean J Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0041","first-page":"1851","article-title":"Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG","volume":"41","author":"Murthy","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0042","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.2967\/jnumed.109.064345","article-title":"Clinical imaging characteristics of the positron emission mammography camera: PEM Flex Solo II","volume":"50","author":"MacDonald","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0043","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2967\/jnumed.109.064428","article-title":"Initial characterization of a dedicated breast PET\/CT scanner during human imaging","volume":"50","author":"Bowen","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0044","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.2967\/jnumed.111.100958","article-title":"Clinical performance of 2 dedicated PET scanners for breast imaging: initial evaluation","volume":"53","author":"Iima","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0045","first-page":"229","article-title":"Comparison of SPECT and planar Tc-99m sestamibi (MIBI) imaging in patients with carcinoma of breast","volume":"35","author":"NagarajN","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0046","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00006231-199516030-00007","article-title":"99mTc-MIBI mammoscintigraphy of breast masses. Early and delayed imaging","volume":"16","author":"Lu","year":"1995","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0047","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s00259-012-2279-5","article-title":"Clinical usefulness of breast-specific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer: a systemic review and meta-analysis","volume":"40","author":"Sun","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0048","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1524-4741.2011.01077.x","article-title":"Negative predictive value of breast-specific gamma imaging in low suspicion breast lesions: a potential means for reducing benign biopsies","volume":"17","author":"Kessler","year":"2011","journal-title":"Breast J"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0049","doi-asserted-by":"crossref","first-page":"W69","DOI":"10.2214\/AJR.10.6105","article-title":"Results of a multicenter patient registry to determine the clinical impact of breast-specific gamma imaging, a molecular breast imaging technique","volume":"198","author":"Weigert","year":"2012","journal-title":"AJR Am J Roentogenol"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0050","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s12149-019-01364-7","article-title":"Distribution pattern of FDG uptake using ring-type dedicated breast PET in comparison to whole-body PET\/CT scanning in individual breast cancer","volume":"33","author":"Sakaguchi","year":"2019","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0051","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1148\/radiol.10100454","article-title":"Breast cancer: Comparative effectiveness of positron emission mammography and MR Imaging in presurgical planning for the ipsilateral breast","volume":"258","author":"Berg","year":"2011","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0052","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2214\/AJR.16.17223","article-title":"Multimodality imaging for evaluating response to neoadjuvant chemotherapy in breast cancer","volume":"208","author":"Rauch","year":"2017","journal-title":"AJR"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0053","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/RLU.0000000000000248","article-title":"99mTc-sestamibi using a direct conversion molecular breast imaging system to assess tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer","volume":"38","author":"Mitchell","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0054","first-page":"341","article-title":"Usefulness of positron emission mammography in the evaluation of response to neoadjuvant chemotherapy in patients with breast cancer","volume":"8","author":"Soldevilla-Gallardo","year":"2018","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0055","first-page":"1049","article-title":"Single static view 99mTc-sestamibi scintimammography predicts response to neoadjuvant chemotherapy and is related to MDR expression","volume":"20","author":"Cayre","year":"2002","journal-title":"Int J Oncol"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0056","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1158\/1078-0432.CCR-16-0738","article-title":"18F-fluoromisonidazole PET and activity of neoadjuvant nintedanib in early HER2-negative breast cancer: a window-of-opportunity randomized trial","volume":"23","author":"Quintela-Fandino","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0057","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1007\/s00259-018-4099-8","article-title":"89Zr-trastumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up","volume":"45","author":"Bensch","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0058","article-title":"Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol","author":"Jones","year":"2019","journal-title":"Breast Cancer"},{"key":"10.1053\/j.semnuclmed.2022.02.005_bib0059","unstructured":"IAEA. IAEA launches drive to bridge big global gap in cancer care. 2022. IAEA Home page. Accessed February 7, 2022."}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299822000198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299822000198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:40:44Z","timestamp":1757544044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299822000198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0001299822000198"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2022.02.005","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Clinical Value of Breast Specific Gamma Imaging and Positron Imaging: An Update","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2022.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}